[IgA nephropathy: from predicting progression to treatment]

Duodecim. 2006;122(2):215-22.
[Article in Finnish]
No abstract available

Publication types

  • Comparative Study
  • Review

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use
  • Angiotensin II Type 1 Receptor Blockers / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Combined Modality Therapy
  • Disease Progression
  • Female
  • Finland
  • Glomerulonephritis, IGA / diagnosis*
  • Glomerulonephritis, IGA / mortality
  • Glomerulonephritis, IGA / therapy*
  • Humans
  • Kidney Function Tests
  • Male
  • Predictive Value of Tests
  • Prognosis
  • Renal Dialysis / statistics & numerical data*
  • Risk Assessment
  • Severity of Illness Index
  • Survival Rate
  • Treatment Outcome

Substances

  • Adrenal Cortex Hormones
  • Angiotensin II Type 1 Receptor Blockers
  • Angiotensin-Converting Enzyme Inhibitors